← Evidence map

ArticleClinical therapeutics2021

Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use.

Hideharu Hagiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 34362568